AbbVie Director Susan Quaggin Acquires Stock Equivalent Units

This Form 4 filing reports that Susan E. Quaggin, a director of AbbVie Inc., acquired 62 stock equivalent units on June 30, 2026, at a price of $251.64 per share, bringing her total holdings to 853 units. The transaction represents the crediting of director fees to an unfunded book account that earns returns equivalent to AbbVie stock. The units are part of a deferred compensation arrangement where director fees are distributed over a period equal to the director's years of board service, generally commencing at age 65 or upon retirement from the board. The balance includes stock equivalent units acquired through a dividend reinvestment feature. This filing demonstrates the ongoing compensation and retention arrangements for AbbVie board members.